We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMEA Sets Out Requirements for Cell-Based Medicines
EMEA Sets Out Requirements for Cell-Based Medicines
July 15, 2008
Companies hoping to market cell-based medicinal products (CBMPs) in the EU may get some direction from a final guideline recently published by the European Medicines Agency (EMEA).
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor